Last checked at 20 Oct 2008 07:00
20 October 2008
Director dealings
Synairgen plc ("Synairgen" or the "Company") was notified on 17 October that on the same day John Ward, Finance Director, acquired 22,000 ordinary shares of 1p each in the Company ("Ordinary Shares") at 22 pence per share, equating to 0.01 per cent of the Company's issued Ordinary Share capital. Following this acquisition, Mr Ward has a beneficial interest of 44,692 Ordinary Shares, equating to 0.21 per cent of the Company's issued Ordinary Share capital.
The Company was also notified on 17 October that on the same day Simon Shaw, non-executive chairman, exercised 700,000 of his Founder Options at nominal value. Following this exercise, Mr Shaw has a beneficial interest of 805,400 Ordinary Shares, equating to 3.71 per cent of the Company's issued share capital.
Application has been made to AIM, a market of the London Stock Exchange plc, for the admission of 700,000 Ordinary Shares (the "New Ordinary Shares"). The New Ordinary Shares are being admitted pursuant to the exercise of options under the Synairgen Chairman's 2004 New Share Option Agreement. It is expected that dealing in the New Ordinary Shares, which will rank pari passu in all respects with the existing issued share capital of the Company, will commence on 24 October 2008.
For further information:
| Synairgen plc John Ward | +44 2380 512800 |
| Teathers Limited Shaun Dobson/Claes Spang | +44 20 7426 9000 |